AD1058 is an orally active, selective, and blood-brain barrier permeable inhibitor of ATR . AD1058 exhibits in vivo anticancer activity, inhibiting cell proliferation, disrupting the cell cycle, and inducing Apoptosis . AD1058 can be utilized in research on brain and central nervous system metastases stemming from advanced solid tumors.